Alzheimers
-
Study Links Alcohol Flush Reaction Gene Variant to Higher Alzheimer’s Risk
University of Florida researchers have linked a common genetic quirk — the one that turns faces red after a glass of wine…
-
Study Links Alcohol Flush Reaction to Significantly Higher Alzheimer’s Risk
For millions of people, a glass of wine brings an immediate, unmistakable flush. That red face has long been dismissed as a…
-
Arginine Prevents Toxic Protein Clumps in Brains of Alzheimer’s Mice
TOKYO — The amino acid arginine, a compound cheap enough to be sold as a bodybuilding supplement, stopped toxic proteins from clumping…
-
Japanese Study Finds Common Amino Acid May Fight Alzheimer’s
A research team in Japan has published findings suggesting that arginine, a widely available and inexpensive amino acid, may reduce toxic protein…
-
Arginine May Slow Alzheimer’s Progression in Animal Studies
TOKYO, June 6, 2026 — infopulsetoday.com — Researchers in Japan have made a promising discovery in the fight against Alzheimer’s disease, reporting…
-
Scientists Find Molecular Switch Locking Alzheimer’s Inflammation On
LA JOLLA, June 5 — Researchers at Scripps Research have made a significant discovery in understanding the molecular mechanism behind the chronic…
-
Scripps Research Finds STING Protein Fuels Alzheimer’s Inflammation
LA JOLLA, June 5 — A research team at Scripps Research has identified a specific biochemical alteration that drives chronic inflammation in…
-
Scripps Research Discovery Shifts Alzheimer’s Focus from Plaques to Inflammation
La Jolla, June 5, 2026 — cybernewschronicle.com — For years, the dominant theory behind Alzheimer’s disease has centered on sticky protein clumps…
-
Single Molecule Key to Stopping Alzheimer’s Brain Inflammation
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
-
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
July 18, 2024 — infopulsetoday.com — The path to the FDA’s July 15 approval of donanemab was paved with controversy, clinical risk,…
-
Fda Approves Donanemab For Alzheimer Disease Treatment
On July 15, 2024, the US Food and Drug Administration (FDA) approved donanemab, a monoclonal antibody developed by Eli Lilly and Company,…
-
New Alzheimer’s Drug Kisunla Carries Significant Brain Risk Factors
The U.S. Food and Drug Administration approved Eli Lilly’s monoclonal antibody donanemab, marketed as Kisunla, on July 15, 2024. The drug is…
-
FDA Approves New Alzheimer’s Treatment Drug Called Kisunla Recently
On 15 July 2024, the U.S. Food and Drug Administration gave the green light to donanemab, a monoclonal antibody marketed as Kisunla,…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds